标题
Safinamide for the treatment of Parkinson’s disease
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 9, Pages 937-943
出版商
Informa UK Limited
发表日期
2017-05-15
DOI
10.1080/14656566.2017.1329819
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Clinical Pharmacokinetics and Pharmacodynamics of Safinamide
- (2016) Thomas Müller et al. CLINICAL PHARMACOKINETICS
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis
- (2016) Tomasz Fundament et al. PLoS One
- Safinamide: First Global Approval
- (2015) Emma D. Deeks DRUGS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- The Concept of Prodromal Parkinson’s Disease
- (2015) Philipp Mahlknecht et al. Journal of Parkinsons Disease
- Premotor and nonmotor features of Parkinsonʼs disease
- (2014) Jennifer G. Goldman et al. CURRENT OPINION IN NEUROLOGY
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Timing of deep brain stimulation in Parkinson disease: A need for reappraisal?
- (2013) Ruth-Mary deSouza et al. ANNALS OF NEUROLOGY
- Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis
- (2013) Damineh Morsali et al. BRAIN
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
- (2012) Alfonso Fasano et al. LANCET NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers
- (2011) Andrea Francesco Daniele Di Stefano et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
- (2010) Adrian Williams et al. LANCET NEUROLOGY
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial
- (2009) Frances M. Weaver JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now